Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer.
about
Novel Molecular Markers for Breast CancerAberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerHaploinsufficient tumor suppressor genes.From General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform.Dmp1α inhibits HER2/neu-induced mammary tumorigenesis.DMP1β, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancerThe oncoprotein HBXIP modulates the feedback loop of MDM2/p53 to enhance the growth of breast cancer.MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1.Human DMTF1β antagonizes DMTF1α regulation of the p14(ARF) tumor suppressor and promotes cellular proliferation.Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancer.Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancerInulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapyAberrant expression of cyclin D1 in cancer.Anticancer Effects of the Marine Sponge Lipastrotethya sp. Extract on Wild-Type and p53 Knockout HCT116 CellsClinical applications of mouse models for breast cancer engaging HER2/neu.Transcription factors that interact with p53 and Mdm2Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α.Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.PRL-3 promotes breast cancer progression by downregulating p14ARF-mediated p53 expression.
P2860
Q26753160-DC793275-C56A-4A95-8ED4-7F3144E87AE9Q26773907-60A68A5E-A1E6-47AD-A6EC-6D8452D30BD7Q33864922-4E1487AF-17A6-48DC-AA93-AC9CCB22BFB4Q34048030-32FFE574-8563-4E7A-8113-562458C437A4Q35035710-92C631D5-1769-44E6-AFD3-0038169B7D4AQ35434433-437F8BEC-5384-42CD-8DE2-605AA678B29FQ36049982-C3F05067-FBF8-4806-81F1-C325161F2DC0Q36140715-6ECCC284-324A-49A7-80B9-A68383E31CAEQ36394792-3638E803-898F-44CA-941E-CA40E088F8EAQ37218223-C49069D7-571E-48F1-B9D3-66A138B6B1D5Q37306546-4ECE9964-D3C2-41CB-9578-C95703A31199Q37362715-39977211-486F-4C0A-BD4B-5B7B285B1E90Q37580471-4F593434-3E27-44B3-B6E5-C66576A22F4DQ37588738-4ECB180A-CC3A-4317-BBA7-56650DA85CC0Q37607675-1EA9BBB2-91DE-4F9E-A4AD-31644CE6EE19Q38541481-776D6C60-CC62-4880-AEED-136D724982AEQ38838490-A9540BCB-86D6-4F65-AC01-2BD205132065Q38935156-E1D43B90-2920-4490-AE36-657AD5B0FA6BQ49997208-61CD77BF-E56B-47EC-A22B-80D77D5909AD
P2860
Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 October 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer.
@en
Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer.
@nl
type
label
Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer.
@en
Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer.
@nl
prefLabel
Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer.
@en
Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer
@en
P2093
M C Willingham
R D Kendig
T Sugiyama
P2860
P2888
P304
P356
10.1038/ONC.2012.423
P407
P50
P577
2012-10-08T00:00:00Z